Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Alteration of Transforming Growth Factor β Signaling Pathway Predicts Worse Prognosis in Pancreatic Ductal Adenocarcinoma.

Pancreas - 1 Apr 2020

Li Mao, Li Ang, Zhao Xiaochen, Hou Shengzhong, Lu Shan, Mou Yu, Liu Xubao, Cai Shangli, Cao Dan, Tian Bole

Abstract excerpt

OBJECTIVES: Transforming growth factor β (TGF-β) signaling pathway is one of the core pathways in pancreatic ductal adenocarcinoma (PDAC). Prognostic value of TGF-β pathway genes as a functionally related group in PDAC is rarely studied. METHODS: Seventy-two PDAC patients who underwent surgery between November 30, 2015, and September 13, 2017, in West China Hospital, Sichuan University, were identified and...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Carcinoma, Pancreatic Ductal
Share to Genes, Neoplasm

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Palliative Care

Share to Proportional Hazards Models

Share to Radiotherapy, Adjuvant

Share to Receptors, Transforming Growth Factor beta

Share to Smad Proteins

Share to Transforming Growth Factor beta

Source

Identifiers

PMID: 32282767
DOI: 10.1097/MPA.0000000000001522

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Alteration of Transforming Growth Factor β Signaling Pathway Predicts Worse Prognosis in Pancreatic Ductal Adenocarcinoma.PMID 32282767Read ↗

SMAD4 and the TGFβ Pathway in Patients with Pancreatic Ductal AdenocarcinomaSemantic proximity Read ↗

The TGF-β/Smad4 Signaling Pathway in Pancreatic Carcinogenesis and Its Clinical SignificanceSemantic proximity Read ↗

Molecular signature of pancreatic adenocarcinoma: an insight from genotype to phenotype and challenges for targeted therapy.Semantic proximity Read ↗

Pathway-specific genomic alterations in pancreatic cancer across diverse cohortsSemantic proximity Read ↗

RNA sequencing analyses reveal novel differentially expressed genes and pathways in pancreatic cancerSemantic proximity Read ↗

Molecular Pathogenesis of Pancreatic Cancer.Semantic proximity Read ↗

New insight into the role of SMAD4 mutation/deficiency in the prognosis and therapeutic resistance of pancreatic ductal adenocarcinomas.Semantic proximity Read ↗

The role of TGF-β/SMAD4 signaling in cancer.Semantic proximity Read ↗

Molecular alterations and targeted therapy in pancreatic ductal adenocarcinoma.Semantic proximity Read ↗

Molecular classification as prognostic factor and guide for treatment decision of pancreatic cancer.Semantic proximity Read ↗

Convergence for Inactivation of TGFβ Signaling Is a Common Feature of Advanced Pancreatic CancerSemantic proximity Read ↗

Identification of Critical Pathways and Potential Key Genes in Poorly Differentiated Pancreatic AdenocarcinomaSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.